Name: Foamix Pharmaceuticals Ltd. (FOMX) Stock
Brand: Foamix Pharmaceuticals Ltd.
Rating: 4.5 (3 reviews)

FOMX Latest News, Press Relases and Analysis

All

Press Releases

6 years ago - By: Seeking Alpha - Mentions: MNLO

Menlo's partner LEO Pharma remedies Finacea Foam supply issues

6 years ago - By: Menlo Therapeutics Inc. - Mentions: MNLO

Menlo Therapeutics and Foamix Pharmaceuticals Complete Merger, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications

6 years ago - By: Seeking Alpha - Mentions: MNLO

Menlo Therapeutics up 20% ahead of Foamix merger & key data readout

6 years ago - By: Benzinga - Mentions: GSX NOW SAR WEX ...

Stocks That Hit 52-Week Highs On Thursday

6 years ago - By: Rigrodsky & Long P.A.

FOAMIX PHARMACEUTICALS LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger

6 years ago - By: Benzinga - Mentions: INO MOR XBI ACAD ...

The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies

6 years ago - By: Foamix Pharmaceuticals Ltd.

Foamix Announces Integrated Efficacy Results from the FMX103 1.5% Topical Minocycline Foam Phase 3 Program for Rosacea

6 years ago - By: Seeking Alpha - Mentions: MNLO

Shareholders back Foamix/Menlo tie-up

6 years ago - By: Foamix Pharmaceuticals Ltd.

Foamix Announces Publication of Phase 3 Studies Evaluating FMX103 for the Treatment of Papulopustular Rosacea in Journal of the American Academy of Dermatology

6 years ago - By: StockNews.com - Mentions: CETX FLNT POPE SNNA ...

Best & Worst Performing Small Cap Stocks for January 15, 2020

6 years ago - By: Seeking Alpha - Mentions: GM

Foamix Pharma's Amzeeq on preferred list at Express Scripts

6 years ago - By: Foamix Pharmaceuticals Ltd.

Foamix Announces AMZEEQ™ (minocycline) Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S.

6 years ago - By: Seeking Alpha

Foamix up 7% on U.S. acne foam launch

6 years ago - By: Foamix Pharmaceuticals Ltd.

Foamix Announces AMZEEQ™ (minocycline) Topical Foam Available in Pharmacies Nationwide on January 13th for the Treatment of Moderate to Severe Acne

6 years ago - By: Halper Sadeh LLP - Mentions: IPHS RARX

Merger Investigation Alert: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - IPHS, FOMX, RARX

6 years ago - By: Halper Sadeh LLP - Mentions: CARO FIT

SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Sale of these Companies is Fair to Shareholders - CARO, FIT, FOMX

6 years ago - By: Kahn Swick & Foti

FOAMIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Foamix Pharmaceuticals Ltd. - FOMX

6 years ago - By: Foamix Pharmaceuticals Ltd.

Foamix Announces Enrollment Completion of Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam

6 years ago - By: Monteverde & Associates PC

URGENT NEWS: Monteverde & Associates PC Announces an Investigation of FOAMIX PHARMACEUTICALS LTD - FOMX

6 years ago - By: WeissLaw LLP - Mentions: MNLO

Foamix Pharmaceuticals Ltd. (FOMX) Stock News

FOMX Latest News, Press Relases and Analysis

Menlo's partner LEO Pharma remedies Finacea Foam supply issues

Menlo Therapeutics and Foamix Pharmaceuticals Complete Merger, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications

Menlo Therapeutics up 20% ahead of Foamix merger & key data readout

Stocks That Hit 52-Week Highs On Thursday

FOAMIX PHARMACEUTICALS LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger

The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies

Foamix Announces Integrated Efficacy Results from the FMX103 1.5% Topical Minocycline Foam Phase 3 Program for Rosacea

Shareholders back Foamix/Menlo tie-up

Foamix Announces Publication of Phase 3 Studies Evaluating FMX103 for the Treatment of Papulopustular Rosacea in Journal of the American Academy of Dermatology

Best & Worst Performing Small Cap Stocks for January 15, 2020

Foamix Pharma's Amzeeq on preferred list at Express Scripts

Foamix Announces AMZEEQ™ (minocycline) Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S.

Foamix up 7% on U.S. acne foam launch

Foamix Announces AMZEEQ™ (minocycline) Topical Foam Available in Pharmacies Nationwide on January 13th for the Treatment of Moderate to Severe Acne

Merger Investigation Alert: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - IPHS, FOMX, RARX

SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Sale of these Companies is Fair to Shareholders - CARO, FIT, FOMX

FOAMIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Foamix Pharmaceuticals Ltd. - FOMX

Foamix Announces Enrollment Completion of Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam

URGENT NEWS: Monteverde & Associates PC Announces an Investigation of FOAMIX PHARMACEUTICALS LTD - FOMX

SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd.